GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wakamoto Pharmaceutical Co 4512.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

277

-1.07%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥9.91bn

FY2017FY2026

Net income

¥227.2m

FY2017FY2026

Free cash flow

−¥1.05bn

FY2017FY2026

Shareholders' equity

¥12.01bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥9.91bn¥7.79bn¥7.74bn¥8.66bn¥8.38bn¥8.89bn¥10.92bn¥10.74bn¥10.90bn¥10.83bn
Gross profit¥4.73bn¥3.62bn¥3.54bn¥4.11bn¥4.36bn¥4.49bn¥6.19bn¥6.12bn¥6.08bn¥5.86bn
Research and development—¥419.1m¥513.3m¥580.5m¥594.0m¥641.5m¥1.73bn¥1.61bn¥1.38bn¥1.14bn
Operating income¥255.5m−¥457.8m−¥195.5m¥142.0m¥285.4m−¥754.9m−¥996.3m−¥391.0m¥177.3m¥87.3m
Net income¥227.2m¥64.4m¥109.0m¥138.3m¥238.5m−¥601.9m−¥1.66bn−¥181.3m¥126.0m¥94.7m
Diluted earnings per share6.551.863.143.986.87-17.34-47.73-5.223.632.73

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥16.50bn¥15.00bn¥15.42bn¥15.71bn¥14.95bn¥14.57bn¥15.98bn¥18.18bn¥17.85bn¥17.89bn
Cash and short-term investments¥2.01bn¥2.95bn¥3.66bn¥3.88bn¥3.23bn¥2.84bn¥2.88bn¥3.26bn¥3.85bn¥3.61bn
Total liabilities¥4.49bn¥3.39bn¥3.39bn¥3.80bn¥3.47bn¥3.19bn¥4.04bn¥4.42bn¥3.75bn¥3.99bn
Debt¥400.0m¥100.0m¥130.7m¥529,000¥2.6m¥2.6m¥3.7m¥5.3m¥42.1m¥208.5m
Shareholders' equity¥12.01bn¥11.61bn¥12.03bn¥11.91bn¥11.48bn¥11.39bn¥11.95bn¥13.76bn¥14.11bn¥13.90bn
Shares outstanding35m35m35m35m35m35m35m35m35m35m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥486.9m−¥592.5m−¥107.3m¥631.9m¥339.2m¥163.4m−¥155.1m−¥114.5m¥555.7m¥1.10bn
Capital spending−¥564.5m−¥450.1m−¥555.7m−¥211.2m−¥368.1m−¥482.3m−¥207.3m−¥596.3m−¥426.0m−¥348.5m
Free cash flow−¥1.05bn−¥1.04bn−¥663.0m¥420.8m−¥29.0m−¥318.8m−¥362.3m−¥710.8m¥129.7m¥749.7m
Dividends paid−¥104.0m−¥103.3m−¥103.9m−¥480,000−¥498,000−¥511,000−¥612,000−¥103.6m−¥103.7m−¥103.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥2.43bn¥2.60bn¥2.93bn¥2.21bn¥2.17bn¥1.98bn¥2.00bn¥1.93bn
Gross profit¥952.8m¥1.22bn¥1.51bn¥975.9m¥1.02bn¥922.7m¥931.7m¥839.6m
Operating income−¥136.4m¥67.7m¥383.5m−¥52.4m−¥143.3m−¥116.2m−¥64.9m−¥187.3m
Net income¥6.7m¥12.2m¥349.1m−¥25.6m−¥108.5m¥83.6m¥122.6m−¥130.4m
Diluted earnings per share0.190.3510.06-0.74-3.122.413.53-3.76
Cash from operations———−¥572.0m————
Capital spending———−¥351.0m————
Free cash flow———−¥923.0m————
Total assets¥15.86bn¥16.50bn¥15.84bn¥14.88bn¥14.72bn¥15.00bn¥15.10bn¥15.26bn
Cash and short-term investments¥1.92bn¥2.01bn¥1.67bn¥1.91bn¥2.40bn¥2.95bn¥3.30bn¥3.62bn
Debt¥157.7m¥400.0m¥100.0m¥100.0m¥100.0m¥100.0m¥100.0m¥100.0m
Shareholders' equity¥11.72bn¥12.01bn¥12.09bn¥11.59bn¥11.42bn¥11.61bn¥11.89bn¥11.95bn

Financial ratios

Data as of 3 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin47.7%46.5%45.8%47.4%52.0%50.5%—
Operating margin2.6%-5.9%2.1%1.6%3.4%-8.5%—
Net margin2.3%0.8%1.4%1.6%2.8%-6.8%—
Return on equity1.9%0.6%0.9%1.2%2.1%-5.3%—
Return on assets1.4%0.4%0.7%0.9%1.6%-4.1%—
Free cash flow yield0.8%-1.4%4.4%8.3%7.0%6.4%—
Revenue growth27.2%0.7%-10.6%3.3%-5.8%-18.5%—
Earnings growth252.6%-40.9%-21.2%-42.0%-139.6%-63.7%—
Current ratio3.48x4.38x4.96x4.18x4.29x4.46x—
Debt to equity0.03x0.01x0.01x0.01x0.01x0.01x—
Equity ratio72.8%77.4%78.0%75.8%76.8%78.1%—
Interest coverage134.85x-519.04x300.17x245.70x496.41x-1326.80x—
R&D as a share of sales—5.4%6.6%6.7%7.1%7.2%15.8%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%-0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.6%2.2%-1.2%
Operating income21.6%—11.9%
Net income18.0%—27.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin47.2%46.9%48.4%52.3%
Operating margin-1.1%-0.8%-1.4%-1.7%
Net margin1.6%1.6%0.3%-1.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings45.4154.071.353.532.3-18.0-5.1-52.677.7101.8
Price to sales1.01.31.00.80.91.20.80.90.90.9

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2019FY2018FY2017FY2016FY2015
Paid in the year6.003.003.003.003.003.003.003.00
  • 1.1-for-1 split · 26 Sept 1995
  • 11-for-10 split · 28 Mar 1989

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.